Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs
29 oct. 2014 09h00 HE
|
Relmada Therapeutics, Inc.
NEW YORK, NY--(Marketwired - October 29, 2014) - Relmada Therapeutics, Inc. (OTCQB: RLMD), a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline,...